Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.
Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children.
Unusual symptoms and syndromes in multiple sclerosis.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2+) release from acidic Ca(2+) stores.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
B-cell targeted therapeutics in clinical development.
A novel method for calculating prevalence of multiple sclerosis in Australia.
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Serum lactate as a novel potential biomarker in multiple sclerosis.
Alemtuzumab and multiple sclerosis: Is it safe?
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
SIRT1 is decreased during relapses in patients with multiple sclerosis.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.

Pages